All Articles

Review Article 
Targeting pathogenic mechanisms in marginal zone lymphoma: from concepts and beyond
Jennifer K. Lue, Owen A. O’Connor, Francesco Bertoni
Annals of Lymphoma
  2020;
4:
7  
Review Article 
Prognostic factors and risk of transformation in marginal zone lymphoma
Juan Pablo Alderuccio, Izidore S. Lossos
Annals of Lymphoma
  2020;
4:
6  
Review Article 
A narrative review of survival normalization in non-Hodgkin lymphoma: useful for better patient counselling and an endpoint for clinical trials?
Lasse H. Jakobsen, Andreas K. Øvlisen, Sandra Eloranta, Martin Bøgsted, Marianne T. Severinsen, Karin E. Smedby, Matthew J. Maurer, Tarec C. El-Galaly
Annals of Lymphoma
  2020;
4:
5  
Review Article 
Minimal residual disease (MRD) in mantle cell lymphoma
Marco Ladetto, Rita Tavarozzi, Christiane Pott
Annals of Lymphoma
  2020;
4:
4  
Editorial 
Growing (up) together: understanding lymphoma in the adolescent and young adult population
Bruce D. Cheson, Meghan E. Gutierrez
Annals of Lymphoma
  2020;
4:
3  
Review Article 
Recent advances in the first-line treatment of mantle cell lymphoma
Morgane Cheminant, Martin Dreyling, Olivier Hermine
Annals of Lymphoma
  2020;
4:
2  
Review Article 
Targeting CDK4/6 in mantle cell lymphoma
Christina Lee, Xiangao Huang, Maurizio Di Liberto, Peter Martin, Selina Chen-Kiang
Annals of Lymphoma
  2020;
4:
1  
Editorial 
Better understanding and new challenges in high grade lymphomas
Astrid Pavlovsky
Annals of Lymphoma
  2019;
3:
13  
Case Report 
PD-L1 expression and response to nivolumab in a case of relapsed/refractory lymphomatoid granulomatosis
Jonathan Weiss, Tera Mayer, Noah Brown, Ryan A. Wilcox
Annals of Lymphoma
  2019;
3:
12  
News 
Application of the CARE guideline as reporting standard in the Annals of Lymphoma
Editorial Office
Annals of Lymphoma
  2019;
3:
11  
Review Article 
New drugs for the management of relapsed or refractory diffuse large B-cell lymphoma
Clémentine Sarkozy, Laurie H. Sehn
Annals of Lymphoma
  2019;
3:
10  
Review Article 
A survey of the therapeutic landscape in peripheral T-cell lymphomas: the importance of expert hematopathology review in the era of targeted therapies and precision medicine
Anthony J. Scott, Charles W. Ross, Ali M. Gabali, Ryan A. Wilcox
Annals of Lymphoma
  2019;
3:
9  
Review Article 
Front-line therapy in elderly patients with mantle cell lymphoma
Victor M. Orellana-Noia, Johanna C. Kluin-Nelemans, Michael E. Williams
Annals of Lymphoma
  2019;
3:
8  
Review Article 
Risk stratification and management algorithms for patients with diffuse large B-cell lymphoma and CNS involvement
Teresa Calimeri, Paolo Lopedote, Andrés J. M. Ferreri
Annals of Lymphoma
  2019;
3:
7  
Case Report 
Sensorineural hearing loss in a patient with follicular lymphoma treated with bendamustine and rituximab
Gabrielle C. Rule, Aaron Esmaili, Chan Yoon Cheah
Annals of Lymphoma
  2019;
3:
5  
Review Article 
Venetoclax for the treatment of mantle cell lymphoma
Victor S. Lin, Mary Ann Anderson, David C. S. Huang, Andrew W. Roberts, John F. Seymour, Constantine S. L. Tam
Annals of Lymphoma
  2019;
3:
4  
Review Article 
Mantle cell lymphoma pathology update in the 2016 WHO classification
Luis Veloza, Inmaculada Ribera-Cortada, Elias Campo
Annals of Lymphoma
  2019;
3:
3  
Review Article 
Is there a role for immunomodulatory drugs in the treatment of mantle cell lymphoma?
Alexandra Albertsson-Lindblad, Mats Jerkeman
Annals of Lymphoma
  2019;
3:
2  
Review Article 
Aggressive B-cell lymphomas—from morphology to molecular pathogenesis
Bo-Jung Chen, Falko Fend, Elias Campo, Leticia Quintanilla-Martinez
Annals of Lymphoma
  2019;
3:
1  
Review Article 
Risk stratification of mantle cell lymphoma (MCL)
Nora Liebers, Peter Dreger, Martin Dreyling, Sascha Dietrich
Annals of Lymphoma
  2018;
2:
10  
Review Article 
Immunotherapy in non-Hodgkin lymphoma
Caron A. Jacobson, Philippe Armand
Annals of Lymphoma
  2018;
2:
9  
Review Article 
Diffuse large B-cell lymphoma—who should we FISH?
Deborah M. Stephens, Sonali M. Smith
Annals of Lymphoma
  2018;
2:
8  
Review Article 
Novel markers for determining risk and evaluation of minimal residual disease in diffuse large B-cell lymphoma
Vincent Camus, Sydney Dubois, Fabrice Jardin, Hervé Tilly
Annals of Lymphoma
  2018;
2:
7